Sponsor pipeline

Grigore T. Popa University of Medicine and Pharmacy clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

Show 1 trial with minor changes only

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

First posted	Trial	Phase	Status
2026-10-15	NCT07875582 Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal Adenocarcinoma		Recruiting
2026-10-14	NCT07874373 Magnesium Supplementation for the Prevention of Cisplatin-Induced Nephrotoxicity		Completed

Not charted: 8 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Get alerts when Grigore T. Popa University of Medicine and Pharmacy's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.